Back
Royalty Pharma PLC Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
RPRX
Royalty Pharma PLC
Last Price:
$32.51
Seasonality Move:
-4.37%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RPRX is experiencing slight buying pressure.
Royalty Pharma PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.27 | Buy |
20-day SMA: | 31.89 | Buy |
50-day SMA: | 32.58 | Buy |
200-day SMA: | 29.01 | Buy |
8-day EMA: | 32.3 | Buy |
20-day EMA: | 32.17 | Buy |
50-day EMA: | 31.93 | Buy |
200-day EMA: | 29.91 | Buy |
Royalty Pharma PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 55.87 | Buy |
Chaikin Money Flow: | 795226 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.23 - 32.55) | Buy |
Bollinger Bands (100): | (27.44 - 33.5) | Buy |
Royalty Pharma PLC Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Royalty Pharma PLC Stock
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 32.71 while RPRX 8-day simple moving average is 32.27, which is a Buy signal.
-
The stock price of RPRX is 32.71 while Royalty Pharma PLC 20-day SMA is 31.89, which makes it a Buy.
-
Royalty Pharma PLC 50-day simple moving average is 32.58 while RPRX share price is 32.71, making it a Buy technically.
-
RPRX stock price is 32.71 and Royalty Pharma PLC 200-day simple moving average is 29.01, creating a Buy signal.
RPRX Technical Analysis vs Fundamental Analysis
Sell
28
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy or a Sell?
-
Royalty Pharma PLC stock is rated a SellThe current Royalty Pharma PLC [RPRX] share price is $32.71. The Score for RPRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Royalty Pharma PLC Stock Info
Market Cap:
14.2B
Price in USD:
32.71
Share Volume:
2.6M
Royalty Pharma PLC 52-Week Range
52-Week High:
34.20
52-Week Low:
24.05
Sell
28
Royalty Pharma PLC (RPRX)
is a Sell
Royalty Pharma PLC Share Price Forecast
-
What is the Royalty Pharma PLC stock price today?The Royalty Pharma PLC stock price is 32.71 USD today.
-
Will RPRX stock go up or go down?Royalty Pharma PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Royalty Pharma PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma PLC is overvalued.
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 32.71 while RPRX 8-day exponential moving average is 32.30, which is a Buy signal.
-
The stock price of RPRX is 32.71 while Royalty Pharma PLC 20-day EMA is 32.17, which makes it a Buy.
-
Royalty Pharma PLC 50-day exponential moving average is 31.93 while RPRX share price is 32.71, making it a Buy technically.
-
RPRX stock price is 32.71 and Royalty Pharma PLC 200-day simple moving average is 29.91, creating a Buy signal.
Fundamental Analysis of Royalty Pharma PLC
Is Royalty Pharma PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.31 per share, an increase this year of $0.44 per share, and an increase next year of $0.65 per share.
Technical Analysis of Royalty Pharma PLC
Should I short Royalty Pharma PLC stock?
-
RPRX Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting Royalty Pharma PLC is a Buy
-
Royalty Pharma PLC Relative Strength Index (RSI) is 55.87, which suggest Royalty Pharma PLC is overbought
-
The Bollinger Bands (25) for Royalty Pharma PLC is (31.23 - 32.55), which suggest Royalty Pharma PLC is a Buy
-
The Bollinger Bands (100) for Royalty Pharma PLC is (27.44 - 33.5), which suggest Royalty Pharma PLC is a Buy
* Royalty Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.